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1. Introduction
Anaphylactic shock is a relatively rare systemic anaphylaxis
reaction. The sensitized body is invaded by external antigen
substances, the immune mechanism lead to strongly
multiple organs involvement syndrome in a short time and
if not been treated in time will cause death [1]. Clinical
reports [2] think the anaphylactic shock have complex
causes, has the characteristics of hard to predict and fast
onset, and contributed to great threat to anaphylactic shock
patient’s life health. It is one of the important prevention
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 diseases of clinical emergency treatment. This research 
made a retrospectively analysis on the clinical data and 
treatment of 24 anaphylactic shock patients in our hospital 
and provided the reference for clinical treatment of this 
kind emergency treatment diseases.
2. Data and Methods
2.1. General Data
18 cases of anaphylactic shock patients received treatment
in our hospital from October 2012 to October 2014 were
randomly selected, with 10 males and 8 females. The ages
were between 14–64 years old, the average age was(30.6
± 5.4)years old. The clinical investigation data showed all
the selected anaphylactic shock patients had no history
of allergies and they had anaphylactic shock within 3–42
min after they had contact with allergens, average of (7.6 ±
1.4) min. There were 3 cases occurred within 5 minutes, 12
cases occurred between 5–30 min and 1 case occurred after
more than 30 min. The basic data of anaphylactic shock
patients did not affect study.
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2.2. Research Methods
Retrospective analysis was made on the basic information 
such as clinical  characteristics,  performance and 
emergency treatment and others of 18 cases of anaphylactic 
shock patients.
2.3. Emergency Treatment
18 cases of anaphylactic shock patients were treated by the 
following emergency measures: (1) Take the anaphylactic 
shock patients away from the allergen immediately. For the 
patients caused by blood transfusion, stopped transfusion 
immediately and sealed up for inspection. For the patients 
caused by drug, stopped the drug immediately and closely 
observed the vital signs of anaphylactic shock patients. 
(2) Gave the anti-shock treatment, selected intramuscular
injection of 0.5–1 mg epinephrine hydrochloride (0.1%)
according to the tolerance of anaphylactic shock patients.
The dosage of children is around 0.025 mg/kg, then
intravenous drip of  dopamine (5–10 μg/kg/min) was
gave to maintain according to the blood pressure of
patients, 1000–2000 mL (1/3 colloidal solution + 2/3
crystalloid solution) was administrated fast within 120
min. (3) Gave the anti-allergy treatment, gave high-dose
of dexamethasone or hydrocortisone immediately, at the
same time, use antihistamine drugs diphenhydramine or
promethazine hydrochloride according to the situation of
anaphylactic shock patients, and appropriately gave vitamin
C and calcium, etc. (4) The treatment of complications,
those with severe lar yngeal  edema, prepared for
tracheotomy, and gave cricothyroid membrane puncture,
those with bronchial asthma, gave spasmolysis and asthma
treatment. (5) Besides that, treated the anaphylactic
shock patients with the following methods: keep warm,
oxygen intake, smooth respiratory tract and symptomatic
treatment, etc. In the process of the above treatment,
a closed observation should be made on anaphylactic
shock patient’s blood pressure, heart rate, pulse, oxygen




Through the clinical manifestation of the 18 cases of
anaphylactic shock patients, it was found that 16 cases of
anaphylactic shock patients were indifferent, 14 cases of
anaphylactic shock patients had the symptoms of nausea,
dizziness, palpitation, chest tightness, etc; 4 cases had
the symptoms of itching and urticarial, etc; 18 cases of
anaphylactic shock patients had arterial pressure not
exceeded 70 mmHg, all of them had sallow breathing; 2
cases had the symptoms of difficult breathing. The clinical
manifestations’ main system distributions are shown in
Table 1.
3.2. Allergen
Through the retrospectively analysis, it was found that the 
drug-induced anaphylactic shock accounted for 88.89%. 
Among them, antimicrobials accounted for 7 cases, 
mostly penicillin and cephalosporin drugs; Chinese patent 
drug accounted for 6 cases, mostly Shuanghuanglian 
and compound salvia miltiorrhiza drugs; other drugs 
accounted for 3 cases, biotoxins accounted for 5.55%; bee 
sting accounted for 1 case, blood transfusion accounted for 
5.55%; and blood products accounted for 1 case.
3.3. Emergency Treatment Results
After the symptomatic treatment of 18 cases of anaphylactic 
shock patients, 17 cases of anaphylactic shock patients are 
recovered. The recovery rate reached 94.44% and 1 case of 




Anaphylactic shock is a kind of severe clinical emergency
treatment diseases. The disease can cause damage to
solid organs in a short time and trigger systemic allergic
reaction. It will cause death in a serious condition,  has
serious impact on allergic shock patients’ life. Most of the
Table 1. Main System Distributions of Allergic Shock Clinical Manifestations. 
Involved System Clinical Manifestation
Breathing System
Prang asthma, chest congestion, breathing difficulties associated with dying, lung wheezing sound moist 
crackles, laryngeal edema, nasal obstruction, no breathing.
Cardiovascular System
Pale face, lower blood pressure, chest tightness, heart palpitations, accelerated heart rate, wet and cool body, 
blue jaundice of lip or acrocyanosis, pulse is thin or can’t be tested, cardiac arrest, weak or disappeared heart 
sound. 
Nervous System
Restlessness, head bilges, lightheadedness, chills, limb numbness, cold sweat, loss of consciousness, 
convulsions.
Gastroenteric System Nausea, vomiting, abdominal distension, abdominal pain, diarrhea, gatism.
Urinary System Facial edema, urinary incontinence.
Skin and Appendages Itching, skin flush, urticarial.
Eyes Conjunctival congestion, giddiness, blurred vision, blacked out.
Other Hearing impairment, tinnitus.
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clinical studies have shown that the cause of the disease is 
complex, mainly caused by external sensitization antigen 
that invading the body. The main antigenic substances 
include polysaccharide, medicine, biological toxin, blood 
products, etc. The anaphylactic shock patients’ allergic 
threshold is very low, therefore, we should avoid drug 
abuse during the emergency treatment, in order to avoid 
other inflammation reaction [3].
4.2. Analysis of Clinical Characteristics 
The main clinical manifestations of anaphylactic shock 
include haziness of spiritual mind, nausea, dizziness, 
palpitation, chest tightness, low blood pressure, itching, 
hives, breathing difficulties, etc. The organ system that 
mainly involved  include respiratory system, cardiovascular 
system, nervous system, gastrointestinal system, urinary 
system, skin and accessories, etc. In this study, 94.44% 
anaphylactic shock patients got shock within 30 minutes, 
the results indicated that the disease has the clinical 
characteristics of rapid and critical. The analysis showed 
that among the 18 anaphylactic shock patients, 6 cases of 
anaphylactic shock patients did not show any sign when 
shock occurred, which showed most of the anaphylactic 
shock had no clinical signs. What is more, anaphylactic 
shock has the clinical characteristics of hard to predict, 
complex allergen and causing death, etc. Therefore, 
mastering the clinical characteristics of the disease has very 
important meaning for the disease emergent treatment [4].
4.3. Analysis of Emergency Treatment 
The measures for anaphylactic shock patients must be took 
in time. The emergent treatments such as keeping away from 
the allergen, anti-shock therapy, anti-allergic treatment and 
prevention of complications were took for allergic shock 
patients. Keeping away from the allergen is to cut off the 
source of the reaction, and provide a basis for follow-up 
work of emergency treatment. Adrenaline used for anti-
shock treatment has the utility of fast diastolic bronchospasm 
and shrinking small peripheral blood vessels. It also can 
fight with abnormal reaction media release, regulate and 
control many links of immune response.  Therefore, the 
drug is the first selection medicaments of anti-shock [5]. 
Anti-allergic treatment mainly used the dexamethasone or 
hydrocortisone. Dexamethasone has anti-inflammatory, anti-
rheumatism, anti-allergic and immune suppression effect. 
Hydrocortisone is a natural glucocorticoid, which the anti-
inflammatory effect is remarkable. Diphenhydramine is a kind 
of antihistamines drug. It has the effect of restraining central 
nervous and has certain relief for the inflammation caused 
by anaphylactic shock. Vitamin C and calcium supplements 
can replenish nutrition and improve allergic shock patients’ 
immune function. Allergic shock patients will be followed 
by symptoms such as laryngeal edema, bronchial asthma, 
etc. whether these complications are treated correctly will 
affect the rescue work, and critical situation will lead to death, 
while symptomatic treatment can effectively relieve such 
complications. In the process of emergency treatment, pay 
close attention to the vital signs of anaphylactic shock patients, 
which can provide certain references for emergent treatments 
[6]. In this research, after symptomatic treatment measures of 
the 18 cases of anaphylactic shock patients, 17 cases of patients 
were recovered. The recovery rate reached 94.44%. 1 case of 
anaphylactic shock patients died because of not having timely 
treatment. This study achieved satisfactory results through 
timely and effective emergency treatment, it also illustrated 
that the effective diagnosis and treatment is the important 
guarantee of successful cure of allergic shock patients.
4.4. Conclusion
By analyzing the clinical data of 18 patients with anaphylactic 
shock, it is believed that mastering the clinical characteristics 
of anaphylactic shocks have an important diagnosis 
and guidance significance for the emergency treatment. 
Emergency physicians and nurses should understand and 
update the knowledge timely. In response to save this kind of 
urgent disease, we should find and judge promptly, choose 
the right measures according to the situation of anaphylactic 
shock patients. At the same time, quickly carry out the rescue 
work, to ensure the life and health of anaphylactic shock 
patients.
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